Efficacy of rituximab as a single-agent therapy for the treatment of granulomatous and lymphocytic interstitial lung disease in patients with common variable immunodeficiency
- Resource Type
- Short Communication
- Source
- In
The Journal of Allergy and Clinical Immunology: In Practice March 2019 7(3):1055-1057 - Subject
- Language
- ISSN
- 2213-2198